Diverse Hematological Malignancies Including Hodgkin-Like Lymphomas Develop in Chimeric MHC Class II Transgenic Mice
Silke H. Raffegerst, Gabriele Hoelzlwimmer, Sandra Kunder et al. · 2009
Read Diverse Hematological Malignancies Including Hodgkin-Like Lymphomas Develop in Chimeric MHC Class II Transgenic Mice by Silke H. Raffegerst, Gabriele Hoelzlwimmer, Sandra Kunder et al. (2009) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0008539.txt.
Description
Silke Raffegerst and co-authors report blood cancers in transgenic mice in a 2009 PLOS ONE paper. Their mice carry a chimeric MHC class II gene called DR4. MHC molecules present antigen fragments to immune cells. The homozygous mouse line spontaneously develops diverse hematological malignancies. That happens at a high frequency of about seventy percent. Tumors split evenly between T cell and B cell types.
The malignancies include lymphoblastic T cell lymphomas and Hodgkin-like lymphomas. Such variety in one mouse line is unusual. The model may reveal how a single immune gene change unleashes many cancer types. It offers a system for testing treatments across blood cancers.
Catalog record
| CREATOR | Silke H. Raffegerst, Gabriele Hoelzlwimmer, Sandra Kunder et al. |
|---|---|
| YEAR | 2009 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 51 KB |
| LICENSE | Creative Commons Attribution License |
| RIGHTS | CC BY |
| SOURCE | PLOS ONE |
Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0008539